Source: JCO Precision Oncology. Unidades: FFCLRP, FM, FMRP
Subjects: NEOPLASIAS CEREBRAIS, NEUROBLASTOMA, FARMACOTERAPIA, PROTEÍNAS QUINASES, SARCOMA
ABNT
VINCE, Carolina Sgarioni Camargo et al. Beyond clinical trials: understanding neurotrophic tropomyosin receptor kinase inhibitor challenges and efficacy in real-world pediatric oncology. JCO Precision Oncology, v. 8, p. 1-14, 2024Tradução . . Disponível em: https://doi.org/10.1200/PO.23.00713. Acesso em: 27 abr. 2025.APA
Vince, C. S. C., Brassesco, M. S., Mançano, B. M., Gregianin, L. J., Mariano, C. S., Mata, J. F. da, et al. (2024). Beyond clinical trials: understanding neurotrophic tropomyosin receptor kinase inhibitor challenges and efficacy in real-world pediatric oncology. JCO Precision Oncology, 8, 1-14. doi:10.1200/PO.23.00713NLM
Vince CSC, Brassesco MS, Mançano BM, Gregianin LJ, Mariano CS, Mata JF da, Silva MO, Caran EMM, Ferman SE, Cristófani LM, Odone Filho V, Valera ET. Beyond clinical trials: understanding neurotrophic tropomyosin receptor kinase inhibitor challenges and efficacy in real-world pediatric oncology [Internet]. JCO Precision Oncology. 2024 ; 8 1-14.[citado 2025 abr. 27 ] Available from: https://doi.org/10.1200/PO.23.00713Vancouver
Vince CSC, Brassesco MS, Mançano BM, Gregianin LJ, Mariano CS, Mata JF da, Silva MO, Caran EMM, Ferman SE, Cristófani LM, Odone Filho V, Valera ET. Beyond clinical trials: understanding neurotrophic tropomyosin receptor kinase inhibitor challenges and efficacy in real-world pediatric oncology [Internet]. JCO Precision Oncology. 2024 ; 8 1-14.[citado 2025 abr. 27 ] Available from: https://doi.org/10.1200/PO.23.00713